Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
about
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finCloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitorHuman monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitorActivation of coagulation and fibrinolysis during dengue virus infection.Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.Differential protease expression by cutaneous squamous and basal cell carcinomas.Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-betaPlasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsTwo different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cellsGeneration in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid miceEndothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.Effects of sulfonylureas on the synthesis and secretion of plasminogen activator from bovine aortic endothelial cellsAutonomous functions of structural domains on human tissue-type plasminogen activatorRole of plasminogen activator in pemphigus vulgaris.Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.Plasma t-PA and PAl-1 antigen concentrations in non-insulin dependent diabetic patients: effects of treatment modality on fibrinolysisCharacterization of seven human melanoma cell lines: melanogenesis and secretion of plasminogen activators.Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitorPlasminogen activator-specific inhibitors produced by human monocytes/macrophages.Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis.The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1Effect of dimethyl sulfoxide on human carcinoma cells, inhibition of plasminogen activator synthesis, change in cell morphology, and alteration of response to cholera toxin.Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture.Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically relatedActivated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.The fibrinolytic system of the vessel wall and its role in the control of thrombosis.Pemphigus research: new directions. An editorial review.Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.
P2860
Q24300911-771C73AF-EBAB-49C0-9B71-F5E84881E152Q24655336-A26C8548-06E2-4297-9BD8-6AD54C1B4FB7Q24682654-96912C33-A439-4BD1-95F8-062C7D55F412Q33335829-B93D3F49-3E7F-4164-8BF5-D3FC5D74F4B1Q33781945-5BC38BF6-22A7-45DE-9828-7F59E932EBD3Q34202408-955567C5-2A40-403E-816A-465E7362954BQ34205401-CAFC52B9-D511-46C5-8125-B7DD6AB027E1Q34217461-1F6C5804-7462-46FD-9C2D-F0BB32596DF9Q34484687-70FEF85C-A9E6-483F-8579-4A1DAA6A8097Q34518795-22778D25-4712-488B-BB6A-8244871C699BQ34535595-C5C3DEF1-8DCE-4613-80D3-39D116DE2C92Q34617979-8C401CB0-A8C0-48D3-A49C-FD6DA6D4C4F8Q34832169-03E6016E-9434-47CB-AA06-ECBE052712BEQ35059478-514B729D-E6D2-4C83-9E24-FBF8BAFA939AQ35552418-54664813-5FD3-4B3F-B37C-836302590BB5Q35580262-DE3A69E2-00F3-4908-8523-C7F0663AA95FQ35586105-6479511A-53D0-4922-A902-D8013119D25DQ35613963-5CDF29DD-2413-4DDE-B4B0-6863D25EE703Q35815953-2BD92F7B-5215-4FC4-9B7B-E480F2D0F1DDQ35819933-C327193B-A825-491E-8BA2-D51AD3F86A43Q35939161-7B79AE58-D05A-4489-B1F3-76586E2C5CF3Q36027456-81DCAAFA-136D-4663-8006-30FA7D07BB3BQ36218668-0B853842-5A20-49D4-BDFD-98C73D11B840Q36221987-60D14E7B-1DEB-48BF-9A41-93089FE8930CQ36223450-31673DED-2F14-41E9-B213-F94FAC0F8F25Q36351900-D32CEA23-BABB-4FE1-B73A-6DB06F5462A0Q36353359-D7725FC7-2856-4EA5-9DC8-4F417F279482Q36355159-84013452-6C08-492B-AF53-EDEF42162294Q36430764-B4027080-6EB5-408C-9954-769BCCFDFF0FQ36670521-1190448C-BA75-4B7A-BCE6-EF24F09F123BQ36722539-C4BA4C1F-369C-4C58-9649-2307592C23CEQ36953321-019842B8-197A-4F76-8AAB-176288C7A652Q37027295-E230F8CD-F705-44CD-8DD3-9B456A340AD2Q37300820-FCAC41BE-F362-4CAF-9D6D-372531A8F7BDQ37510853-9CC17F51-A137-494D-8983-93D6E863D857Q37558755-02BC4F2B-1BEE-494B-AE27-CBAF9D5404EDQ37678210-52F4B001-8DCB-4AC4-84B0-B65B14364D69Q38000918-A56581FE-BC43-45AD-80B1-4AB501099399Q38170742-FA5CBFCA-184F-4EE1-B547-95B862813BE7Q38583085-FD88C41D-3F64-434E-8F42-4E3B0095B428
P2860
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Detection of an unusually stab ...... d by bovine endothelial cells.
@en
Detection of an unusually stab ...... d by bovine endothelial cells.
@nl
type
label
Detection of an unusually stab ...... d by bovine endothelial cells.
@en
Detection of an unusually stab ...... d by bovine endothelial cells.
@nl
prefLabel
Detection of an unusually stab ...... d by bovine endothelial cells.
@en
Detection of an unusually stab ...... d by bovine endothelial cells.
@nl
P2093
P2860
P356
P1476
Detection of an unusually stab ...... d by bovine endothelial cells.
@en
P2093
D J Loskutoff
D Lawrence
J A van Mourik
L A Erickson
P2860
P304
P356
10.1073/PNAS.80.10.2956
P407
P577
1983-05-01T00:00:00Z